Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417664 · ClinicalTrials.gov registry record
Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium When Compared to Propofol or Midazolam in Cardiac Surgery Patients
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 90
- Enrollment target
NCT00417664: Completed study, sponsored by Stanford University.
NCT00417664 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00417664 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this chart review study is to determine whether the use of dexmedetomidine, a selective α2-adrenergic receptor agonist with sedative, analgesic, and antinociceptive properties, would be associated with a lower incidence of delirium when compared to propofol and midazolam. We hypothesize that sedation with dexmedetomidine following cardiac surgery with CPB will be associated with a lower incidence of postoperative delirium.
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2002-04 |
| Est. Completion | 2004-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00417664
The ClinicalTrials.gov registry entry for NCT00417664 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.
NCT00417664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00417664 about?
NCT00417664 is a clinical study titled "Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium When Compared to Propofol or Midazolam in Cardiac Surgery Patients". The purpose of this chart review study is to determine whether the use of dexmedetomidine, a selective α2-adrenergic receptor agonist with sedative, analgesic, and antinociceptive properties, would be associated with a lower incidence of delirium when compared to propofol and midazolam. We hypothesi...
What is the current status of trial NCT00417664?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2002-04. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00417664?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT00417664?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.